PerkinElmer, Inc. Announces Partnership With Ion Signature Technology To Enhance Evaluation Of Complex GC/MS Samples

BOSTON – PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced a new partnership with Ion Signature Technology, Inc. (IST). Users of the new PerkinElmer Clarus® 600 GC/MS now have the option to incorporate Ion Signature Quantitative Deconvolution Software™ customized for the Clarus family during data processing for fast and accurate data review and evaluation.

MORE ON THIS TOPIC